Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 21, 2015
The effects of the monoamine stabilizer (-)-OSU6162 on craving in alcohol dependent individuals: A human laboratory studyLotfi Khemiri, Pia Steensland, Joar Guterstam, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|May 3, 2011
Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted ratsJohan P Rung, Emilia Rung, Anette M Johansson, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 28, 2004
The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognitionMarie Nilsson, Arvid Carlsson, Katarina Rydén Markinhuhta, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|March 21, 2008
Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilizationJohan P Rung, Emilia Rung, Lisa Helgeson, et al.Acta Neuropsychiatrica|September 23, 2014
Tolerability and efficacy of the monoaminergic stabilizer (-)-OSU6162 (PNU-96391A) in Huntington's disease: a double-blind cross-over studyAngelica Kloberg, Radu Constantinescu, Marie Karin Lena Nilsson, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|August 26, 2011
II. In vitro evidence that (-)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptorsEthan S Burstein, Maria L Carlsson, Michelle Owens, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|August 30, 2011
I. In vivo evidence for partial agonist effects of (-)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptorsMaria L Carlsson, Ethan S Burstein, Angélica Kloberg, et al.Acta Neurologica Scandinavica|August 23, 2018
Open study with (-)-OSU6162 in multiple sclerosis-related fatigueSara Haghighi, Sara Forsmark, Arvid Carlsson, et al.Brain and Behavior|February 2, 2021
Open-label study with the monoamine stabilizer (-)-OSU6162 in myalgic encephalomyelitis/chronic fatigue syndromeSara Haghighi, Sara Forsmark, Olof Zachrisson, et al.Acta Neuropsychiatrica|October 25, 2016
1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorderMaria Ljungberg, Marie K L Nilsson, Karin Melin, et al.Pageof 3